Share This Page
Drug Price Trends for PHENAZOPYRIDINE
✉ Email this page to a colleague
Average Pharmacy Cost for PHENAZOPYRIDINE
Drug Name | NDC | Price/Unit ($) | Unit | Date |
---|---|---|---|---|
PHENAZOPYRIDINE 100 MG TAB | 65162-0681-10 | 0.13552 | EACH | 2024-12-18 |
PHENAZOPYRIDINE 100 MG TAB | 69367-0191-01 | 0.13552 | EACH | 2024-12-18 |
PHENAZOPYRIDINE 100 MG TAB | 69367-0611-01 | 0.13552 | EACH | 2024-12-18 |
PHENAZOPYRIDINE 100 MG TAB | 69367-0162-04 | 0.13552 | EACH | 2024-12-18 |
PHENAZOPYRIDINE HCL 95 MG TAB | 00536-1411-07 | 0.12055 | EACH | 2024-12-18 |
>Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
PHENAZOPYRIDINE Market Analysis and Financial Projection
Phenazopyridine Market Analysis and Price Projections
Introduction to Phenazopyridine
Phenazopyridine, commonly known by brand names such as Pyridium and Uro-Pain, is a medication used to relieve pain, burning, and the frequent need to urinate associated with urinary tract infections, dysuria, and interstitial cystitis. It belongs to the miscellaneous genitourinary tract agents drug class.
Market Size and Growth
The global phenazopyridine hydrochloride market has shown significant growth over the years. As of 2018, the market size was valued at a substantial amount and is projected to expand at a Compound Annual Growth Rate (CAGR) from 2019 to 2025[4].
Market Segmentation by Type
The phenazopyridine hydrochloride market is segmented by type, with various strengths available, including 95 mg, 100 mg, and 200 mg oral tablets. Each type has its own market share and revenue. For instance, the global market share and revenue by type from 2013 to 2018 have been analyzed, showing the dominance of certain strengths in the market[1].
Market Segmentation by Applications
Phenazopyridine is used in several applications, primarily for treating dysuria and interstitial cystitis. The market is segmented by these applications, with detailed consumption and revenue data available for each segment. This segmentation helps in understanding the demand and growth potential in different therapeutic areas[1].
Regional Market Analysis
The market for phenazopyridine hydrochloride is analyzed across various regions, including the United States, Europe, China, Japan, Southeast Asia, India, Brazil, and GCC countries. Each region has its own market dynamics, consumption volume, and revenue forecasts from 2013 to 2025. For example, the United States and Europe are significant markets due to their large patient populations and advanced healthcare systems[1].
Market Dynamics and Development
The market is influenced by several factors, including driving forces such as increasing prevalence of urinary tract infections and interstitial cystitis, and restraining factors like competition from generic drugs and regulatory challenges. The report also tracks market news, such as mergers, acquisitions, and new investments, which can impact market growth[1].
Price Trends and Projections
The prices of phenazopyridine vary based on the strength and quantity of the tablets. Here are some current price ranges:
- 95 mg: From $13.15 for 30 tablets, with a per-unit price ranging from $0.44 to $0.59[2].
- 100 mg: From $13.97 for 6 tablets, with a per-unit price ranging from $2.33 to $1.03 depending on the quantity[2].
- 200 mg: From $16.82 for 6 tablets, with a per-unit price ranging from $2.80 to $1.14 depending on the quantity[2].
Future Price Projections
For the period from 2018 to 2025, the global phenazopyridine hydrochloride market is expected to see stable price trends. Here are some key projections:
- Global Consumption Volume and Value Forecast: The market is expected to grow in terms of both consumption volume and value, with detailed forecasts provided for different regions and types of phenazopyridine hydrochloride[1].
- Price Forecast: The price trends are expected to remain relatively stable, with minor fluctuations based on market dynamics and competition from generic drugs[1].
Impact of Generic Drugs
The presence of authorized generic drugs can significantly impact the pricing of phenazopyridine. Authorized generics have been shown to reduce retail generic prices by 4-8% and wholesale generic prices by 7-14% during the 180-day exclusivity period. This competition can lead to lower prices for consumers and reduced revenues for the first-filer generic manufacturers[5].
Market Competition
The phenazopyridine hydrochloride market is competitive, with several major players involved. The report provides insights into the profiles, product analysis, sales, price, revenue, and gross margin of these top players. This competition drives innovation and pricing strategies in the market[1].
Key Takeaways
- Market Growth: The global phenazopyridine hydrochloride market is expected to grow at a steady CAGR from 2019 to 2025.
- Price Stability: Prices are expected to remain relatively stable, with minor fluctuations due to market dynamics.
- Regional Variations: Different regions have varying market sizes and growth rates.
- Impact of Generics: Authorized generic drugs can reduce prices and impact the revenues of first-filer generic manufacturers.
- Competitive Landscape: The market is highly competitive, with several major players influencing market trends.
FAQs
1. What is phenazopyridine used for? Phenazopyridine is used to relieve pain, burning, and the frequent need to urinate associated with urinary tract infections, dysuria, and interstitial cystitis.
2. What are the common strengths of phenazopyridine available in the market? The common strengths available are 95 mg, 100 mg, and 200 mg oral tablets.
3. How does the presence of authorized generic drugs affect the market? Authorized generic drugs can reduce retail and wholesale prices, leading to lower consumer costs and reduced revenues for first-filer generic manufacturers.
4. What regions are significant in the phenazopyridine hydrochloride market? The United States, Europe, China, Japan, Southeast Asia, India, Brazil, and GCC countries are significant regions in the market.
5. What is the projected growth rate of the phenazopyridine hydrochloride market? The market is projected to expand at a CAGR from 2019 to 2025, though the exact rate is not specified in the sources provided.
Sources
- Global Phenazopyridine Hydrochloride Consumption Market Research Report 2013-2025 - Maia Research[1]
- Phenazopyridine Prices, Coupons, Copay Cards & Patient Assistance - Drugs.com[2]
- Pharmacy Market Outlook Summer 2024 - Vizient Inc.[3]
- Phenazopyridine hydrochloride Market Size, Share - Prof Research[4]
- Authorized Generic Drugs: Short-Term Effects and Long-Term Impact - Federal Trade Commission[5]
More… ↓